Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03923673 · ClinicalTrials.gov registry record · NA
Minimally Invasive Pericardiotomy as a New Treatment for Heart Failure
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03923673: Completed NA study, sponsored by Mayo Clinic.
NCT03923673 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03923673, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Researchers are studying the safety and efficacy of a minimally invasive treatment called a pericardiotomy, which creates a small opening in the sac that surrounds the heart. Researchers will test the short and long term effects of this procedure by monitoring subjects heart function and symptoms.
Primary Outcome
The number of major cardiac and cerebrovascular events reported.
Interventions
- PROCEDURE Pericardiotomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2020-10-15 |
| Phase | NA |
What the finished NCT03923673 record still lists
NCT03923673 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Pericardiotomy is the first listed.
NCT03923673 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03923673 about?
NCT03923673 is a clinical study titled "Minimally Invasive Pericardiotomy as a New Treatment for Heart Failure". Researchers are studying the safety and efficacy of a minimally invasive treatment called a pericardiotomy, which creates a small opening in the sac that surrounds the heart. Researchers will test the short and long term effects of this procedure by monitoring subjects heart function and symptoms.
What is the current status of trial NCT03923673?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2019-05-01. Estimated completion is 2020-10-15.
What interventions are being tested in trial NCT03923673?
The interventions under investigation include: Pericardiotomy (PROCEDURE).
Who is sponsoring clinical trial NCT03923673?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03923673's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI